Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Total Non-Current Liabilities (2023 - 2025)

Guardian Pharmacy Services' Total Non-Current Liabilities history spans 3 years, with the latest figure at $190.7 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 13.9% year-over-year to $190.7 million; the TTM value through Dec 2025 reached $190.7 million, up 13.9%, while the annual FY2025 figure was $190.7 million, 13.9% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $190.7 million at Guardian Pharmacy Services, up from $189.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $210.8 million in Q3 2024 and bottomed at $167.1 million in Q1 2025.
  • The 3-year median for Total Non-Current Liabilities is $179.8 million (2023), against an average of $182.2 million.
  • The largest YoY upside for Total Non-Current Liabilities was 13.9% in 2025 against a maximum downside of 10.2% in 2025.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $179.8 million in 2023, then fell by 6.89% to $167.4 million in 2024, then rose by 13.9% to $190.7 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Total Non-Current Liabilities are $190.7 million (Q4 2025), $189.3 million (Q3 2025), and $170.5 million (Q2 2025).